Short-term Dual Anti Platelet Therapy in Patients With ACS Treated With the COMBO Dual-therapy Stent
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1500 participants.
Also called NCT02118870
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,500 participants
- Sponsor
- Diagram B.V.
- Registry
-
NCT02118870 -
2013-005571-40
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT02118870. Randomized; no masking; primary purpose treatment. Start 2014-06-10 (actual); primary completion 2017-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Short-term Dual Anti Platelet Therapy in Patients With ACS Treated With the COMBO Dual-therapy Stent
- Acronym
- REDUCE
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Treatment 90 days DAPT
- Intervention (Drug)
- Treatment 360 days DAPT
- Lead sponsor
- Diagram B.V.
Record details
- Record id
cardio:ct-nct02118870- Content hash
c060b38ef8e25f861579d314a82cd954f5ef0d7f637a3485df6e7ce838563f85